Completed PHASE1 INTERVENTIONAL 1-arm NCT02176317

Autologous Umbilical Cord Blood Infusion for Children With Autism Spectrum Disorder (ASD)

Sponsor: Duke University

Interventions Autologous Umbilical Cord Blood

Updated 10 times since 2017 Last updated: Dec 2, 2019 Started: Jun 30, 2014 Primary completion: Dec 31, 2015 Completion: Dec 31, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1 trial investigates Autism Spectrum Disorder and is currently completed. Duke University leads this study, which shows 10 recorded versions since 2014 — indicating substantial longitudinal coverage. This study adds to the longitudinal dataset for psychiatric treatment development.

Status Flow

Change History

10 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Jan 2020 — Jan 2021 [monthly]

Completed PHASE1
Jul 2019 — Jan 2020 [monthly]

Completed PHASE1

▶ Show 5 earlier versions

Nov 2018 — Jul 2019 [monthly]

Completed PHASE1
Aug 2018 — Nov 2018 [monthly]

Completed PHASE1
Jun 2018 — Aug 2018 [monthly]

Completed PHASE1
Feb 2017 — Jun 2018 [monthly]

Completed PHASE1
Jan 2017 — Feb 2017 [monthly]

Completed PHASE1

First recorded

Jun 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Duke University
PerkinElmer, Inc.
The Marcus Foundation

Data source: Duke University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Durham, United States